191 related articles for article (PubMed ID: 2892257)
21. Determining the optimal dosage regimen for H2-receptor antagonist therapy--a dose validation approach.
Young MD; Frank WO; Dickson BD; Peace KP; Braverman A; Mounce W
Aliment Pharmacol Ther; 1989 Feb; 3(1):47-57. PubMed ID: 2577482
[TBL] [Abstract][Full Text] [Related]
22. Can higher doses of an H2-receptor antagonist accelerate duodenal ulcer healing?
Page MC; Lacey LA; Mills JG; Wood JR
Aliment Pharmacol Ther; 1989 Oct; 3(5):425-33. PubMed ID: 2577498
[TBL] [Abstract][Full Text] [Related]
23. [Ranitidine therapy of duodenal ulcer: comparison of once-a-day and twice-a-day administration. A Swiss multicenter double-blind study].
Aenishänslin W; Bergoz R; Capitaine Y; Egger G; Etienne A; Fumagalli I; Güller R; Hammer B; Kobler E; Leuthold E
Schweiz Med Wochenschr; 1986 May; 116(19):637-41. PubMed ID: 3715441
[TBL] [Abstract][Full Text] [Related]
24. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration.
Alcalá Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Aliment Pharmacol Ther; 1989 Feb; 3(1):103-10. PubMed ID: 2491454
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.
Alcalá Santaella R; Guardia J; Pajares J; Pique J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Hepatogastroenterology; 1989 Jun; 36(3):168-71. PubMed ID: 2666293
[TBL] [Abstract][Full Text] [Related]
26. Comparison between ranitidine 150 mg b.d. and ranitidine 300 mg nocte in the treatment of duodenal ulcer.
Arcidiacono R; Benvestito V; Bonomo GM; Bottari M; Buscarini L; Camarri E; Celle G; Coltorti M; Di Matteo S; Dobrilla G
Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):381-4. PubMed ID: 3525430
[TBL] [Abstract][Full Text] [Related]
27. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134
[TBL] [Abstract][Full Text] [Related]
28. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
Matov V; Metchkov G; Krastev Z; Tchernev K; Mitova R; Márquez M; Torres J; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
[TBL] [Abstract][Full Text] [Related]
29. Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer.
Bianchi Porro G; Dicenta C; Cook T; Humphries TJ
J Clin Gastroenterol; 1987; 9 Suppl 2():14-8. PubMed ID: 2887613
[TBL] [Abstract][Full Text] [Related]
30. A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer.
Alcalá-Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Digestion; 1989; 42(2):79-85. PubMed ID: 2670647
[TBL] [Abstract][Full Text] [Related]
31. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
Hüttemann W
Drugs; 1988; 35 Suppl 3():90-5. PubMed ID: 2905255
[TBL] [Abstract][Full Text] [Related]
32. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic double-blind controlled trial of ranitidine vs placebo in the short-term treatment of duodenal ulcer.
Dobrilla G; de Pretis G; Felder M; Chilovi F
Hepatogastroenterology; 1981 Feb; 28(1):49-52. PubMed ID: 6111528
[TBL] [Abstract][Full Text] [Related]
34. Treatment of active duodenal ulcers with famotidine. A double-blind comparison with ranitidine.
Rohner HG; Gugler R
Am J Med; 1986 Oct; 81(4B):13-6. PubMed ID: 2877569
[TBL] [Abstract][Full Text] [Related]
35. A single nighttime dose of ranitidine 300 mg versus ranitidine 150 mg twice daily in the acute treatment of duodenal ulcer: a European multicenter trial.
Simon B; Bianchi Porro G; Cremer M; Dobrilla G; Haglund U; Dunn SL; Summers K
J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):367-70. PubMed ID: 3531309
[TBL] [Abstract][Full Text] [Related]
36. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
37. Roxatidine in duodenal ulcer.
Habibullah CM; Habeeb MA; Singh SP
J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
[TBL] [Abstract][Full Text] [Related]
38. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study.
Di Mario F; Battaglia G; Saggioro A; Chiozzini P; D'Angelo A; Marin R; Morelli A; Vezzadini P; Buscarini L; Cavassini G
Ital J Gastroenterol; 1991 Jun; 23(5):253-6. PubMed ID: 1742515
[TBL] [Abstract][Full Text] [Related]
39. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
[TBL] [Abstract][Full Text] [Related]
40. Nizatidine as maintenance therapy of duodenal ulcer disease in remission.
Cerulli MA; Cloud ML; Offen WW; Chernish SM; Matsumoto C
Scand J Gastroenterol Suppl; 1987; 136():79-83. PubMed ID: 2892259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]